Do you want to read an article? Please log in or register.
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
Gastrointestinal Cancer
Related content
Gastrointestinal Cancer
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer
Nature
Roth G, Artru P, Bouche O, Williet N, Ghelfi J, Turpin A, Lievre A, Blanc JF, Evrard C, Bachet JB, Parent P, Manceau M, Roustit M, Borowik A, Granger V, Durand A, d'Engremont C, Girard E, Chirica M, Braissand N, Rama N, Modolo E, Hernandez-Vargas H, Georges E, Scoazec JY, Cros J, Hazard S, Ducarouge B, Decaens T, Bernet A, Mehlen P
doi: 10.1038/s41586-026-10436-4
Gastrointestinal Cancer
Tumor Debulking in Combination With Chemotherapy in Multiorgan Metastatic Colorectal Cancer: The ORCHESTRA Randomized Clinical Trial
JAMA
Gootjes EC, Bakkerus L, Adhin AA, Zonderhuis BM, Versteeg KS, Tuynman JB, Meijerink MR, Haasbeek CJA, de Wilt JHW, Grunhagen DJ, Smit EJ, Primrose JM, Bridgewater J, van Meerten E, de Groot JB, Hendriks MP, Oomen-de Hoop E, Buffart TE, Verhoef C, Verheul HMW, ORCHESTRA Study Group
doi: 10.1001/jama.2026.1929
RECOMMENDED
Gastrointestinal Cancer
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
N Engl J Med
Park W, Kasi A, Spira AI, Paz-Ares Rodríguez L, Herzberg BO, Pelster MS, Tolcher AW, Kuboki Y, Kitano S, Shoji H, Wang JS, Berlin JD, Hollebecque A, LoRusso P, Fountzilas C, Cassier PA, Nishina T, Sakai D, Inagaki C, Morgensztern D, Ueno M, Jung M, Kim SW, Jänne PA, Italiano A, You B, Macarulla T, Fujii H, Shetty A, Lu Y, Cui D, Kadam S, Gill SC, Toyoshima J, Saito T, Goldman JW
doi: 10.1056/NEJMoa2600752
Gastrointestinal Cancer
Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical Trial
JAMA Oncol
Reiss KA, Xia M, Akamandisa M, D'Andrea K, Wubbenhorst B, Lord CJ, Pettitt SJ, Tutt ANJ, Brown TJ, O'Hara MH, Schneider C, Teitelbaum U, Hannan Z, Hood R, Tondon R, Vonderheide RH, Domchek SM, Nathanson KL
doi: 10.1001/jamaoncol.2026.0870
Gastrointestinal Cancer
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
Lancet
Shen L, Zhang X, Ji K, Lu L, Wang Q, Guan Q, Yan S, Zhou Y, Yang Y, Huo Z, You J, Ba Y, Ye Y, Chen Y, Wang S, Lv G, Zhang J, Hu X, Yang F, Yu H, Li J, Wang Q, Zhu J, Ji J, ASTRUM-006 Study Group
doi: 10.1016/S0140-6736(26)00974-8
Gastrointestinal Cancer
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab
Eur J Cancer
Vo-Quang E, Campani C, Allaire M, Bouattour M, Regnault H, Marra F, Sutter O, Leroy V, Trepo E, Mouri S, Thabut D, Ozenne V, Sidali S, Hollande C, Boros C, Nahon P, Ganne-Carrié N, Lequoy M, Amaddeo G, Nault JC, Paris Liver Cancer Group
doi: 10.1016/j.ejca.2026.116704
Gastrointestinal Cancer
Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment
Eur J Cancer
Debiais M, Tarabay A, Blanchet-Deverly S, Camilleri GM, Megherbi A, Diebakate L, Collin M, Hollebecque A, Smolenschi C, Valéry M, Pudlarz T, Fuerea AC, Boige V, Ducreux M, Boilève A
doi: 10.1016/j.ejca.2025.116160
Gastrointestinal Cancer
Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not underweight: A nationwide cohort study
Eur J Cancer
Kim HJ, Park JH, Hong JY, Han K, Shen JJ, Park JO, Park YS, Lim HY
doi: 10.1016/j.ejca.2025.116111
Gastrointestinal Cancer
Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer: An analysis of 18,041 patients in the ARCAD CRC database
Eur J Cancer
Wagner AD, Raeisi M, Rakez M, Diasio RD, Margalit O, Zalcberg JR, Venook AP, Douillard JY, Lenz HJ, Heinemann V, Goldberg RM, van Cutsem E, Schmoll HJ, Shi Q, André T, de Gramont A
doi: 10.1016/j.ejca.2026.116694